Healthcare
Compact Proton Therapy Systems Promise Greater Accessibility for Cancer Patients
Innovative compact proton therapy systems are reducing equipment size and costs, potentially making this precise cancer treatment more accessible to patients who previously couldn't access it due to traditional systems' limitations.
Nutriband CEO Discusses AVERSA Technology's Role in Addressing Opioid Crisis on Podcast
Nutriband Inc. CEO Gareth Sheridan highlighted the company's AVERSA abuse-deterrent transdermal technology on a podcast, emphasizing its potential to reduce misuse of high-risk drugs like fentanyl while maintaining patient access.
Earth Science Tech Inc. Expands Multi-Platform Healthcare Strategy Through Strategic Holdings
Earth Science Tech Inc. is building a diversified healthcare portfolio through strategic acquisitions and management of compounding pharmacies, telemedicine platforms, and specialized healthcare providers to create sustainable growth and shareholder value.
Jacksonville Family Transforms Type 1 Diabetes Diagnosis Into Advocacy Through Community Initiative
A Jacksonville family's journey with their son's Type 1 diabetes diagnosis has evolved into Pablo's Pack T1D, a community initiative providing resources and support while participating in the Breakthrough T1D Walk to advance research toward a cure.
GeoVax Advances Mpox/Smallpox Vaccine Toward Phase 3 Trial Amid Global Supply Concerns
GeoVax Labs is preparing to initiate a pivotal Phase 3 trial for its GEO-MVA vaccine in the second half of 2026, addressing critical global supply constraints for orthopoxvirus vaccines while reporting a reduced net loss of $21.5 million for 2025.
Oncotelic Therapeutics Exemplifies Biotech Sector's Shift Toward Pipeline-Driven Valuation
Oncotelic Therapeutics illustrates how biotechnology companies are increasingly being valued based on clinical progress and pipeline assets rather than traditional metrics, representing a fundamental shift in sector valuation practices.
Functional Longevity Summit Dallas 2026 to Bridge Gap Between Medical Innovation and Clinical Practice
The Functional Longevity Summit Dallas 2026 introduces a new model for medical education by providing practical implementation training in precision medicine and regenerative therapies to help healthcare providers improve patient outcomes while optimizing practice performance.
BioElectronics Expands ActiPatch to Taiwan Through Aphrodite Medical Group Partnership
BioElectronics Corporation's expansion of its FDA-cleared ActiPatch device to Taiwan through distributor Aphrodite Medical Group represents a significant shift toward drug-free pain management alternatives in Asian healthcare markets.
Aclarion Authorizes $2.5 Million Stock Buyback, Signaling Confidence in Nociscan Growth
Aclarion's board-approved share repurchase program highlights the company's disciplined capital management and belief that its stock is undervalued despite the ongoing clinical adoption of its Nociscan platform for chronic back pain diagnosis.
Catalyst Crew Technologies Launches Telehealth Platform Targeting Latin American Healthcare Gaps
Catalyst Crew Technologies has launched its telehealth platform in Venezuela, aiming to address infrastructure constraints and fragmented care delivery across Latin America through AI-driven healthcare coordination.
Personalized mRNA Vaccine Shows Promise in Extending Pancreatic Cancer Survival
A personalized mRNA vaccine has demonstrated potential to meaningfully extend survival for pancreatic cancer patients, according to six-year trial results presented at a major oncology conference.
Biotech Valuations Shift as Scientific Progress Gains Financial Recognition
The biotechnology industry is undergoing a transformation where scientific advancement is increasingly quantified as financial assets through fair-value accounting, with companies like Oncotelic Therapeutics demonstrating how clinical progress translates to tangible economic value.
Aclarion Secures U.S. Patent for AI-Driven Chronic Back Pain Assessment Technology
Aclarion has obtained a U.S. patent for its AI-powered platform that analyzes spinal data to identify sources of chronic low back pain, potentially improving surgical outcomes and expanding access to more consistent diagnostics.
Memory Beads Inspired by 116-Year-Old's Habit Launch to Support Alzheimer's Research
A new tactile brain health tool called Peter's Memory Beads, inspired by a 116-year-old man's daily routine, has launched with all proceeds supporting Alzheimer's Association research and services.
Catalyst Crew Technologies Advances Telehealth Platform Development for Latin American Markets
Catalyst Crew Technologies is developing an AI-integrated telehealth platform focused on emerging markets, starting with Venezuela, to improve healthcare coordination and data-driven insights in regions with growing demand for modernized medical services.
Helus Pharma Appoints Neuroscience Veteran Dr. Ken Kramer as Senior Vice President of Medical Affairs
Helus Pharma's appointment of Dr. Ken Kramer, a 20-year neuroscience medical affairs leader, strengthens the company's clinical development capabilities for its novel serotonergic agonists targeting depression and anxiety disorders.
Oncotelic Therapeutics Reports $249 Million Net Income for FY 2025 Driven by Joint Venture Valuation
Oncotelic Therapeutics announced a dramatic financial turnaround with $249 million net income for fiscal year 2025, primarily due to a non-cash gain from its GMP Biotechnology joint venture valuation, signaling potential growth in its oncology and COVID-19 drug pipeline.
NextPlat's PharmcoRx Deploys AI Technology to Automate Pharmacy Prescription Processing
NextPlat Corp's PharmcoRx subsidiary has implemented AI-powered prescription intake and processing technology to automate manual workflows, improve efficiency, reduce costs, and support scalable growth in pharmacy management.
Stonegate Capital Partners Updates Coverage on GoHealth Amid Medicare Advantage Shift
GoHealth Inc. prioritizes retention and member quality over enrollment growth in a disciplined Medicare Advantage market, focusing on protecting its $925 million commissions receivable asset while investing in automation and AI for future efficiency.
New AI Tool Shows Promise for Early Lung Cancer Detection
A new artificial intelligence tool could significantly improve early detection of lung cancer, potentially increasing survival rates for a disease that remains the leading cause of cancer-related deaths worldwide.
Nephros Targets $25 Million Opportunity in Greater New York with New Regional Sales Leader
Nephros appoints Dana Cunningham as dedicated regional sales leader to accelerate growth in the Greater New York market, which it estimates represents a $25 million annual addressable opportunity for point-of-use filtration and services.
Soligenix Reports Positive Interim and Comparative Data for CTCL Treatment HyBryte
Soligenix announced consistent interim response rates from its phase 3 FLASH2 study and positive comparative results for HyBryte against Valchlor in cutaneous T-cell lymphoma, highlighting progress for a disease with limited treatment options.
10X Health Appoints Will Sliger as CMO to Drive Brand and Marketing for Precision Health Platform
10X Health names Will Sliger as Chief Marketing Officer to build the marketing engine behind its personalized health and performance platform, signaling a strategic push to scale its brand and go-to-market operations.
German Sports Nutrition Brand TNT Expands Amazon Presence with Performance Supplements
True Nutrition Technology (TNT) launches its German-made Creatine Monohydrate with Creapure and Synapsensause Pre-Workout on Amazon, marking a key step in U.S. expansion and offering consumers access to high-quality, lab-tested supplements.
ORGANA Liquid Oxygen Now Available on Amazon for U.S. Consumers
ORGANA International expands its digital marketplace presence by offering its Liquid Oxygen supplement on Amazon, tapping into growing consumer demand for convenient liquid wellness products.
HeartBeam Closes $10 Million Public Offering to Accelerate Cardiac Tech Commercialization
HeartBeam Inc. raised $10 million in a public offering to fund the commercialization of its FDA-cleared 12-lead synthesized ECG system and other cardiac technologies.
Two Neuroscientists Awarded 2026 Ralph L. Sacco Scholarships for Brain Health Research
The American Academy of Neurology and the American Heart Association have awarded $150,000 scholarships to Sarah Kettlety and Cali McEntee to study concussion recovery in children and the effects of exercise on brain aging, respectively.
Combination Strategies Reshape Precision Oncology as Lixte Advances First-in-Class PP2A Inhibitor
Lixte Biotechnology's LB-100, a first-in-class PP2A inhibitor designed to enhance chemotherapy and immunotherapy, exemplifies the industry shift toward combination regimens to overcome resistance in solid tumors.
Soligenix Gains EU Orphan Drug Designation for SGX945 in Behçet's Disease, Bolstering Rare Disease Pipeline
The European Commission granted orphan drug designation to Soligenix's SGX945 for Behçet's disease, validating the therapy's potential and supporting the company's rare disease strategy.
Cardio Diagnostics Holdings Gains Attention for AI-Driven Cardiovascular Platform
Cardio Diagnostics Holdings is highlighted as a company to watch due to its AI-powered approach to cardiovascular disease prevention, detection, and management, integrating epigenetics and genetics for personalized insights.